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Previous neuroimaging studies have revealed that both gray matter (GM) and white matter (WM) are 
altered in several morphological aspects in schizophrenia patients. Although several studies reported 
associations between GM and WM alterations in restricted regions, the existence of a global 
association between GM and WM pathologies is unknown. Considering the wide distribution of GM 
morphological changes and the profound genetic background of WM abnormalities, it would be 
natural to postulate a global association between pathologies of GM and WM in schizophrenia. In 
this investigation we studied 35 schizophrenia patients and 35 healthy control subjects using 
T1-weighted magnetic resonance imaging and diffusion tensor imaging (DTI), and investigated the 
association between GM thickness and WM fractional anisotropy (FA) as a proxy of pathology in 
each tissue. To investigate cortical thickness, surface-based analysis was used. The mean cortical 
thickness for the whole brain was computed for each hemisphere and group comparisons were 
performed. For DTI data, mean FA for the whole brain was calculated and group comparisons were 
performed. Subsequently, the correlation between mean cortical thickness and mean FA was 
investigated. Results showed that the mean cortical thickness was significantly thinner and the mean 
FA was significantly lower in schizophrenia patients. Only in the patient group the mean cortical 
thickness and mean FA showed significant positive correlations in both hemispheres. This correlation 
remained significant even after controlling for demographic and clinical variables. Thus, our results 
indicate that the GM and WM pathologies of schizophrenia are intertwined at the global level. 
 





Schizophrenia is a neurodevelopmental disorder with widespread brain alterations. Over the past 
decades, magnetic resonance imaging (MRI) studies have revealed volume reductions in multiple 
brain regions in schizophrenia. Voxel-based morphometry (VBM) is one of the most frequently 
applied techniques used to explore the whole brain without specific presumptions about search areas, 
and volume reductions of widely distributed cortical/subcortical gray matter (GM) regions in 
schizophrenia, including the prefrontal and temporal cortices, have been reported1-3. On the other 
hand, cortical volume is affected by cortical thickness and surface area, both of which can be altered 
independently in human brains4. Cortical thickness is supposed to better reflect cytoarchitectural 
alterations than cortical volumes5, such as the disorganization or low density of neuronal and glial 
cells, and alterations of synaptic spines and passing axons in schizophrenia5-7. Recently the 
surface-based approach8,9 has been increasingly utilized to analyze the cortical thickness in the whole 
brain, and it can be used to directly measure cortical thickness separately from cortical surface area. 
It has revealed reduced cortical thickness in various regions including prefrontal and temporal areas 
in schizophrenia10,11. 
Whereas GM pathology was initially the focus of many brain imaging studies, white matter 
(WM) abnormality in schizophrenia is increasingly being investigated using neuroimaging 
techniques, especially diffusion tensor imaging (DTI)12, which provides information about white 
matter tracts and their organization based on water diffusion. Fractional anisotropy (FA) is the most 
often used DTI index of WM integrity, and reduced FA in schizophrenia has been frequently reported 
in various regions, including the uncinate fasciculus (UF), cingulum bundle, superior longitudinal 
fasciculus (SLF), corpus callosum (CC) and cerebellar peduncles13-18. As a result, the term 
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“disconnection hypothesis”19, which originally denoted the functional disconnection at the synaptic 
level, is often used to stress the relevance of WM pathology. 
As mentioned above, the findings of altered GM and WM in schizophrenia patients are 
increasingly prevalent. However, whether and how GM and WM pathologies are interrelated in the 
neurodevelopmental process have yet to be investigated. Meanwhile, several candidate genetic 
susceptibility factors for schizophrenia have recently garnered attention, and some of the mutations 
in such susceptibility genes are thought to affect the formation and regression of synapses in the 
cortex, which can lead to pathological GM loss. Furthermore, these genes also affect the proliferation 
and differentiation of oligodendrocytes in the white matter, as well as their capacity for myelination, 
which can lead to abnormal white matter integrity20,21. Based on these findings, it is tempting to 
hypothesize that structural abnormalities of GM and WM at the macroscopic level are intertwined in 
the pathological process of schizophrenia. In attempts to answer this question, some studies have 
reported associations between regional GM and WM pathologies22-25. However, to date, no study has 
examined whether there is such an association between GM and WM pathologies at the global level. 
Considering the wide distribution of GM morphological abnormalities and WM integrity changes, 
and the putative genetic background of GM and WM abnormalities, it would be natural to postulate a 
global association between pathologies of GM and WM in schizophrenia. 
In this study, we tried to elucidate the global association between GM cortical thickness and WM 
integrity alterations in schizophrenia, using a surface-based approach and DTI. We hypothesized that 
there would be a positive correlation between cortical thinning and WM integrity reduction in 






Thirty-five schizophrenia patients diagnosed with the patient edition of the Structured Clinical 
Interview for DSM-IV Axis I Disorders (SCID), were recruited. None of the patients had comorbid 
psychiatric disorders. The Positive and Negative Syndrome Scale (PANSS)26 was used to assess the 
severity of clinical symptom with five subscales; negative, positive, activation, depressive and 
cognitive factors27. Thirty-five healthy controls, matched with the patient group in terms of age, 
gender, and education level were recruited. The controls had no history of psychiatric illness, as 
screened with the non-patient edition of the SCID, and it was confirmed that their first-degree 
relatives had no history of psychotic disorders. Exclusion criteria for all individuals included a 
history of head trauma, neurological illness, serious medical or surgical illness, and substance abuse. 
All participants were physically healthy when they undertook the scanning. After receiving a 
complete description of the study, all participants gave written informed consent. The study design 
was approved by the Committee on Medical Ethics of Kyoto University. 
 
MRI Data Acquisition 
All participants underwent MRI scans on a 3-Tesla whole body scanner equipped with a 
receiver-only 8-channel phased-array head coil with a 40-mT/m gradient (Trio, Siemens, Erlangen, 
Germany). The scanning parameters of the T1-weighted three-dimensional magnetization-prepared 
rapid gradient-echo (3D-MPRAGE) sequences were as follows: echo time (TE) = 4.38 ms; repetition 
time (TR) = 2000 ms; inversion time = 990 ms; field of view (FOV) = 225 × 240 mm; 240 × 256 




The scanning parameters for DTI data were as follows: TE = 96 ms, TR = 10500 ms, 96 × 96 
matrix, FOV = 192 × 192 mm, 70 continuous axial slices of 2.0 mm thickness, 81 non-collinear axis 
motion probing gradient, b = 1500 s/mm2. The b = 0 images were scanned preceding every 9 
diffusion weighted images, thus consisting of 90 volumes in total. 
 
Data Processing and Statistical Analysis 
Cortical thickness analysis: 
For cortical thickness analysis in the whole brain, a surface-based approach was applied using 
FreeSurfer tools28,29 (version 4.5.0, http://surfer.nmr.harvard.edu). The 3D-MPRAGE images were 
used to calculate the thickness of the cerebral cortex throughout the cortical mantle. Briefly, the 
processing stream included a Talairach transform of each of the subject's native brain, removal of 
non-brain tissue, and segmentation of GM/WM tissue. The GM/WM boundary was tessellated to 
generate multiple vertices across the whole brain. The cortical surface of each hemisphere was 
inflated to an average spherical surface to locate the pial surface and the GM/WM boundary. The 
entire cortex of each subject was visually inspected, and any topological defects were corrected 
manually, blind to subject identities. Cortical thickness was computed as the shortest distance 
between the pial surface and the GM/WM boundary at each vertex across the cortical mantle. Global 
mean cortical thickness for each subject was computed by averaging cortical thickness of each vertex, 
right and left hemispheres separately. The global mean cortical thicknesses were compared between 
groups, using two-tailed t-tests on SPSS version 19.0 (SPSS, Chicago). The correlations of the global 
mean cortical thicknesses with demographic and clinical data were also assessed using Pearson’s 
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correlation coefficient in SPSS. The statistical significance threshold was set at P < .05. For regional 
cortical thickness analysis, the thickness value at each vertex for each subject was mapped to the 
surface of an average brain template (http://surfer.nmr.mgh.harvard.edu/fswiki/FsAverage), and the 
cortical map of each subject was smoothed with a Gaussian kernel of 10-mm full-width at 
half-maximum. Subsequently, the group comparison between healthy controls and schizophrenia 
patients was performed. The general linear model (GLM) was implemented at each vertex in the 
whole brain to identify brain regions where schizophrenia patients showed significant differences in 
cortical thickness compared with healthy controls, using FreeSurfer's mri_glmfit. The effects of age 
and gender were regressed out in these models. The analyses were performed for the right and left 
hemispheres separately. The cluster forming threshold and clusterwise significance threshold (for 
multiple comparison) were set at P < .05 by Monte Carlo simulation. 
 
DTI Processing 
All DTI data processing and statistical analysis were performed using the programs in FSL ver. 
4.1.430. All source data were corrected for eddy currents and head motion by registering all data to 
the first b=0 image with affine transformation. The FA maps were calculated using the FDT program. 
The tract-based spatial statistics (TBSS) ver. 1.2, which is part of the FSL program, was utilized to 
calculate average FA value for whole brain. First, all subjects’ FA data were normalized into a 
common space using the nonlinear registration tool FNIRT. Normalized FA images were averaged to 
create a mean FA image, which was then thinned to create a “skeleton”, taking only the centers of 
WM tracts common to all subjects. Voxel values of each subject's FA map were projected onto the 
skeleton by searching the local maxima along the perpendicular direction from the skeleton. Skeleton 
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mean FA for each subject was calculated using the fslstats program. Group comparison of this 
skeleton mean FA and its correlation with demographic and clinical data were performed using a 
two-tailed t-test and Pearson’s correlation coefficients respectively, in SPSS. The statistical 
significance level was set at P < .05. 
Voxelwise permutation-based nonparametric inference31 was performed on skeletonized FA data, 
using FSL Randomize ver. 2.5. A group comparison was performed using an analysis of covariance 
(ANCOVA) design, with age and gender as nuisance covariates. Both “healthy controls –
schizophrenia” and “schizophrenia–healthy controls” contrasts were tested, with 10,000 permutations. 
Multiple comparisons were corrected using threshold-free cluster enhancement (TFCE)32, and the 
significance level was set at P < .01. 
 
Correlational Analyses of Cortical Thickness and Skeleton Mean FA 
Subsequently, we investigated the correlations between global mean cortical thickness and skeleton 
mean FA, for both patients and controls on SPSS. Furthermore, in case the correlation between 
global mean cortical thickness and skeleton mean FA was significant, partial correlation coefficient 
was calculated. The demographic and clinical variables revealed to be correlated with global mean 
cortical thickness or skeleton mean FA were used as controlling factors. 
 
Results 
Demographic and Clinical Data 
The demographic and clinical data are shown in Table 1. The schizophrenia group consisted of 
mainly chronic patients with relatively mild symptoms. All of the schizophrenia patients were 
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prescribed antipsychotics. Among our patients, four received typical antipsychotic medication, 22 
received atypical antipsychotics, and nine received both types of medication. 
 
Group Comparison of Cortical Thickness 
The global mean cortical thicknesses of both hemispheres were significantly thinner in schizophrenia 
patients than in healthy controls (Table 2). 
In the vertexwise analysis, the schizophrenia group exhibited reduced cortical thickness compared 
with the healthy group in several regions, including the bilateral superior to middle frontal gyri, 
bilateral insula, right precuneous region, and bilateral inferior temporal areas (Fig. 1). On the 
contrary, the healthy group had no cortical regions thinner than the schizophrenia group. 
 To check if the group difference found in global mean cortical thicknesses was caused by thinning 
in some specific region, we additionally calculated regional mean cortical thickness for each of five 
cortical regions, namely, the frontal, parietal, temporal, and occipital lobes and cingulate cortex, 
according to Desikan et al.33 All regions, except for the left occipital lobe, were significantly thinner 
in schizophrenia patients than in healthy controls (P < .05) (Supplementary Table 1).  
 
Group Comparison of FA 
Skeleton mean FA was significantly lower in schizophrenia than in healthy controls (Table 2). In the 
voxelwise analysis, there was a cluster of significant FA decreases in schizophrenia patients, which 
included widespread WM areas such as the CC, bilateral UF, cortico-spinal tracts, left SLF and 




Correlation Between Global Mean Cortical Thickness and Skeleton Mean FA 
In the schizophrenia group, the global mean cortical thickness of each hemisphere was significantly 
and positively correlated with the skeleton mean FA (Table 3). The global mean cortical thickness 
also showed significant correlation with age (left hemisphere r = -0.513, P = .002; right hemisphere r 
= -0.512, P = .002), and skeleton mean FA was significantly correlated with age (r = -0.566, P 
< .001), education (r = 0.532, P = .001) and duration of illness (r = -0.501, P = .002). None of the 
five subscales of PANSS were significantly correlated with the global mean cortical thickness or the 
skeleton mean FA. No other correlation with demographic or clinical variables was found for global 
mean cortical thickness or skeleton mean FA. 
The partial correlation between global mean cortical thickness and skeleton mean FA remained 
significant after controlling for age, education, and duration of illness (Table 4). 
By contrast, in the healthy group, there was no correlation between the global mean cortical 
thickness and skeleton mean FA. The global mean cortical thickness showed significant correlation 
with age (left hemisphere r = -0.631, P < .001; right hemisphere r = -0.620, P < .001). The skeleton 
mean FA was not significantly correlated with any demographic items. 
 
Discussion 
In this study we showed for the first time that global cortical thinning is positively correlated with 
global WM integrity reduction in schizophrenia. This finding supports the idea that GM and WM 
pathologies in schizophrenia are intertwined at the global level. It should be noted that a similar 
correlation was not found in normal populations, which suggests that this association is not a general 
occurrence in the human brain, such as in aging, but reflects a disease-specific pathological process.  
12 
 
As this is a macroscopic brain imaging study, detailed discussion on the microstructural basis of 
these associations is difficult. However, recent neuropathological findings in schizophrenia, when 
considered in relation to our results, may bridge between two different levels. Global cortical 
thinning detected at a macroscopic level in our study may reflect the reduction of layer-specific 
neuropil density of pyramidal neurons34, such as decreased density of dendritic spines on pyramidal 
neurons of cortical deep layer III revealed in the frontal regions of schizophrenia35,36. On the other 
hand, reduced white matter integrity at a macroscopic level may reflect reductions in the size and 
number of oligodendrocytes and disrupted myelination in schizophrenia37. 
A principal mechanism controlling the formation and regression of synapses, which constitute the 
neuropil, is associated with the schizophrenia susceptibility gene products, such as 
disrupted-in-schizophrenia 1 (DISC1) and neuregulin (NRG)/ErbB, the latter of which modulates 
N-methyl-D-aspartate (NMDA) receptors; activation of which is involved in synapse formation and 
regression20. On the other hand, loss of ErbB4 signaling leads to a decrease in the length of 
oligodendrocyte processes and thinner myelin sheaths38. The intracellular ErbB family signaling 
cascade is triggered by NRG1, which is modulated by DISC1, and the alteration of these affects 
myelin synthesis, differentiation, and proliferation of oligodendrocytes. Importantly, disruption of 
normal myelination of axons has been shown to induce regression or failure of synapses in animal 
experiments39,40. Thus, several schizophrenia susceptibility genes are involved in neurodevelopment, 
bridging between synapse formation/regression and oligodendrocyte function and myelination41. Our 
results, at the macroscopic level, can be considered to support the existence of such coupled 
mechanisms between GM and WM. A schematic representation is shown in Fig. 4. 
Several previous studies have investigated the associations between GM and WM abnormalities 
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in schizophrenia patients. Some of these15,22,25,42 focused on the regional GM and WM networks 
using structural MRI and DTI, while another43 combined functional MRI and DTI data. However, 
none of these studies have researched the pathological association between global GM and WM. Our 
study is the first to indicate the existence of the coupled mechanism between GM and WM 
mentioned above at the global level. In fact, both DISC1 and NRG1 are widely expressed in the 
animal44,45 and human brain46-48, supporting our view.  
We found an association between global cortical thickness and global WM integrity only for 
schizophrenia, suggesting that this association is a reflection of a disease-specific pathological 
process. However, if several candidate genes are commonly involved in the neurodevelopmental 
process of GM and WM, it is feasible that such a GM–WM association would also be found in a 
healthy population, albeit to a lesser extent. In fact, the low-pitched slopes for healthy controls in Fig. 
3 give such an impression. On the other hand, the pathology of schizophrenia has traditionally been 
supposed to be some abnormal process that cannot be attributed to the variation in the normal sample. 
A study with a large sample size may be able to provide an answer to this question. 
We did not find association between symptom severity and any imaging indices in this study. One 
possible interpretation of this is that the global association found in this study is not a “state” marker, 
but rather a “trait” marker of schizophrenia. On the other hand, schizophrenia patients show 
impairments in a broad range of cognitive functions such as general intelligence, working memory, 
and executive function. The global association found in this study may not underlie specific 
cognitive function impairments, but may be the neural basis of the cognitive impairments in 
schizophrenia patients in general. We did not perform cognitive tasks in this study, therefore we 
should be cautious about such speculation. 
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The global cortical thickness reduction in schizophrenia shown in this study is consistent with 
our previous study10. The vertexwise analysis showed that such cortical thinning was most prominent 
in the prefrontal and temporal regions, again consistent with previous studies10,11,49,50. The 
supplementary analysis of regional mean cortical thickness showed a diffuse pattern of reduction in 
cortical thickness in accordance with the results of a previous study51, suggesting that the thinning of 
global cortical thickness was not due to an effect in some specific region, but rather an effect that 
was global in nature. An extensive investigation of region specific GM–WM association might be 
interesting in the future, when the neurodevelopmental hypothesis proposed in this paper turns out to 
be plausible. 
Regarding white matter analysis, FA was found to be reduced at the global level, consistent with 
an earlier study52. Voxelwise analysis revealed that such an FA reduction was profound in widely 
distributed areas, including the CC, bilateral UF, bilateral cortico-spinal tracts, left SLF, and left 
superior fronto-occipital fasciculus, largely compatible with previous studies14-16,37. 
There are several limitations in this study. First, most of the schizophrenia participants had 
relatively mild symptoms and may not be representative of the general population of this disease. 
Second all of the patients were taking antipsychotic medications. Although we confirmed that there 
was no significant correlation of medication level with either global cortical thickness or skeleton 
mean FA, we cannot exclude completely an effect of medication on brain morphology. Third, this 
study was a cross-sectional study, and not a longitudinal or cohort study. Therefore, it is unknown 
how these GM and WM changes occur during the development of schizophrenia pathology. 
Longitudinal studies, especially including high-risk populations, are needed in the future. 
Despite of these limitations, our study is noteworthy because it reveals the global association of 
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GM and WM pathologies in schizophrenia. Future studies will need to investigate the 
neurobiological mechanisms underlying such coupled abnormalities to better understand the 
pathophysiology of this disease. 
 
Funding 
This work was supported by Grant-in-Aid for Scientific Research B (23390290), S (22220003), and 
on Innovative Areas (23118004) and (23120009) from the Ministry of Education, Culture, Sports, 
Science and Technology of Japan; Grant-in-Aid for Young Scientists B (23791329) from Japan 
Society for the Promotion of Science; a research grant from Mitsubishi Pharma Research 
Foundation; a research grant from The Uehara Memorial Foundation; a grant of the NeuroCreative 
Lab (NPO); a research grant from Takeda Science Foundation; a research grant from Research 
Group for Schizophrenia, Japan. These agencies had no further role in the study design, the 
collection, analysis and interpretation of data, the writing of the report, or in the decision to submit 
the paper for publication. 
 
Acknowledgments 
The authors wish to extend their gratitude to Ms. Miho Yoshizumi, Ms. Shiho Ubukata, and Drs. 
Mitsuaki Shimizu, and Keita Uéda for their assistance in data acquisition and processing, to Dr. 
Akiko Hayashi for assistance in statistical analyses, and most of all, to the patients and volunteers for 
participating in the study.  





1. Honea R, Crow TJ, Passingham D, Mackay CE. Regional deficits in brain volume in 
schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry 
2005;162:2233-2245. 
2. Glahn DC, Laird AR, Ellison-Wright I, et al. Meta-analysis of gray matter anomalies in 
schizophrenia: application of anatomic likelihood estimation and network analysis. Biol 
Psychiatry 2008;64:774-781. 
3. Ellison-Wright I, Glahn DC, Laird AR, Thelen SM, Bullmore E. The anatomy of first-episode 
and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry 
2008;165:1015-1023. 
4. Winkler AM, Kochunov P, Blangero J, et al. Cortical thickness or grey matter volume? The 
importance of selecting the phenotype for imaging genetics studies. Neuroimage 
2010;53:1135–1146 
5. Ehrlich S, Brauns S, Yendiki A, et al. Associations of cortical thickness and cognition in patients 
with schizophrenia and healthy controls. Schizophr Bull 2012;38:1050-1062. 
6. Garey L. When cortical development goes wrong: schizophrenia as a neurodevelopmental 
disease of microcircuits. J Anat 2010;217:324-333. 
7. Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal 
neurons in schizophrenia. Arch Gen Psychiatry 2000;57:65-73. 
8. Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface 
reconstruction. Neuroimage 1999;9:179-194. 
9. Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis. II. Inflation, flattening, and a 
17 
 
surface-based coordinate system. Neuroimage 1999;9:195-207. 
10. Kubota M, Miyata J, Yoshida H et al. Age-related cortical thinning in schizophrenia. Schizophr 
Res 2011;125:21-29. 
11. Kuperberg GR, Broome MR, McGuire PK, et al. Regionally localized thinning of the cerebral 
cortex in schizophrenia. Arch Gen Psychiatry 2003;60:878-888. 
12. Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophysical J 
1994;66:259-267. 
13. Ellison-Wright I, Bullmore E. Meta-analysis of diffusion tensor imaging studies in schizophrenia. 
Schizophr Res 2009;108:3-10. 
14. Kubicki M, McCarley R, Westin CF, et al. A review of diffusion tensor imaging studies in 
schizophrenia. J Psychiatr Res 2007;41:15-30. 
15. Miyata J, Yamada M, Namiki C, et al. Reduced white matter integrity as a neural correlate of 
social cognition deficits in schizophrenia. Schizophr Res 2010;119:232-239. 
16. Seal ML, Yucel M, Fornito A, et al. Abnormal white matter microstructure in schizophrenia: A 
voxelwise analysis of axial and radial diffusivity. Schizophr Res 2008;101:106-110. 
17. Walterfang M, Wood SJ, Velakoulis D, Pantelis C. Neuropathological, neurogenetic and 
neuroimaging evidence for white matter pathology in schizophrenia. Neurosci Biobehav Rev 
2006;30:918-948.  
18. Fujiwara H, Namiki C, Hirao K, et al. Anterior and posterior cingulum abnormalities and their 
association with psychopathology in schizophrenia: A diffusion tensor imaging study. 
Schizophrenia Res 2007; 95:215-222.  
19. Friston KJ. The disconnection hypothesis. Schizophr Res 1998;30:115-125. 
18 
 
20. Benett J. Schizophrenia: susceptibility genes, dendritic-spine pathology and gray matter loss. 
Prog Neurobiol 2011;95:275-300. 
21. Karlsgodt KH, Sun D, Jimenez AM, et al. Developmental disruptions in neural connectivity in 
the pathophysiology of schizophrenia. Development Psychopathol 2008;20:1297-1327. 
22. Douaud G, Smith S, Jenkinson M, et al. Anatomically related grey and white matter abnormalities 
in adolescent-onset schizophrenia. Brain 2007;130:2375-2386. 
23. Miyata J, Hirao K, Namiki C, et al. Reduced white matter integrity correlated with 
cortico-subcortical gray matter deficits in schizophrenia. Schizophr Res 2009;111:78-85. 
24. Spoletini I, Cherubini A, Paola MD, et al. Reduced fronto-temporal connectivity is associated 
with frontal gray matter density reduction and neuropsychological deficit in schizophrenia. 
Schizophr Res 2009;108:57-68. 
25. Koch K, Schultz CC, Wagner G, et al. February 9, 2012. Disrupted white matter connectivity is 
associated with reduced cortical thickness in the cingulate cortex in schizophrenia. Cortex  
doi:10.1016/j.cortex.2012.02.001 
26. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for 
schizophrenia. Schizophr Bull 1987;13:261-276. 
27. Lançon C, Aghababian V, Llorca PM, Auquier P. Factorial structure of the positive and negative 
syndrome scale (PANSS): a forced five-dimensional factor analysis. Acta Psychiatr Scand 
1998;97:369-376. 
28. Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface 
reconstruction. Neuroimage 1999;9:179-194. 
29. Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis. II: Inflation, flattening, and a 
19 
 
surface-based coordinate system. Neuroimage 1999;9:195-207. 
30. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image 
analysis and implementation as FSL. Neuroimage 2004;23 Suppl 1:S208-19. 
31. Nichols TE, Holmes AP. Nonparametric permutation tests for functional neuroimaging: a primer 
with examples. Hum Brain Mapp 2001;15:1-25. 
32.  Smith SM, Nichols TE, Threshold-free cluster enhancement: Addressing problems of 
smoothing, threshold dependence and localisation in cluster inference. Neuroimage 
2009;44:83-98. 
33. Desikan RS, Ségonne F, Fischl B, et al. An automated labeling system for subdividing the human 
cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006;31:968- 980. 
34. Lewis DA. Neuroplasticity of excitatory and inhibitory cortical circuits in schizophrenia. 
Dialogues Clin Neurosci 2009;11:269-280. 
35. Glanz LA, Gilmore JH, Lieberman JA, Jarskog LF. Apoptotic mechanisms and the synaptic 
pathology of schizophrenia. Schizophr Res 2006;81:47-63. 
36. Kolluri N, Sun Z, Sampson AR, Lewis D. Lamina-specific reductions in dendritic spine density 
in the prefrontal cortex of subjects with schizophrenia. Am J Psychiatry 2005;162:1200-1202. 
37. Walterfang H, Ciaramidaro A, Adenzato M, et al. Dysfunction of the social brain in schizophrenia 
modulated by intention type: An fMRI study. Soc Cogn Affect Neurosci 2009;4:166-176. 
38. Roy K, Murtie JC, El-Khodor BF, et al. Loss of erbB signaling in oligodendrocytes alters myelin 
and dopaminergic function, a potential mechanism for neuropsychiatric disorders. Proc Natl 
Acad Sci U S A 2007;104:8131-8136. 
39. Höistad M, Segal D, Takahashi N, et al. Linking white and grey matter in schizophrenia: 
20 
 
oligodendrocyte and neuron pathology in the prefrontal cortex. Front Neuroanat 2009;3:1-15. 
40. Takahashi N, Sakurai T, Davis KL, Buxbaum JD. Linking oligodendrocyte and myelin 
dysfunction to neurocircuitry abnormalities in schizophrenia. Prog Neurobiol 2011;93:13-24. 
41. Karlsgodt KH, Sun D, Jimenez AM, et al. Developmental disruptions in neural connectivity in 
the pathophysiology of schizophrenia. Dev Psychopathol 2008;20:1927-1327. 
42. Qiu, A, Tuan, TA, Woon, PS, Hippocampal-cortical structural connectivity disruptions in 
schizophrenia: An integrated perspective from hippocampal shape, cortical thickness, and 
integrity of white matter bundles. Neuroimage 2010;52:1181-1189. 
43. Sui J, Pearlson G, Caprihan A, et al. Discriminating schizophrenia and bipolar disorder by fusing 
fMRI and DTI in a multimodal CCA+ joint ICA model. Neuroimage 2011;57:839-855. 
44. Schurov IL, Handford EJ, Brandon NJ, Whiting PJ. Expression of disrupted in schizophrenia 1 
(DISC1) protein in the adult and developing mouse brain indicates its role in neurodevelopment. 
Mol Psychiatry 2004;9:1100-1110. 
45. Chen MS, Bermingham-McDonogh O, Danehy FT, et al. Expression of multiple Neuregulin 
transcripts in postnatal rat brains. J Comp Neurol 1994;349:389-400.  
46. James R, Adams RR, Christie S, et al. Disrupted in Schizophrenia 1 (DISC1) is a 
multicompartmentalized protein that predominantly localizes to mitochondria. Mol Cell Neurosci 
2004;26:112-122. 
47. Kirkpatrick B, Xu L, Cascella N, et al. DISC1 Immunoreactivity at the light and ultrastructural 
level in the Human neocoterx. J Comp Neurol 2006;497:436–450. 
48. Law AJ, Shannon Weickert C, Hyde TM, et al. Neuregulin-1 (NRG-1) mRNA and protein in the 
adult human. Neuroscience 2004;127:125–136. 
21 
 
49. Goldman AL, Pezawas L, Doz P, et al. Widespread reductions of cortical thickness in 
schizophrenia and spectrum disorders and evidence of heritability. Arch Gen Psychiatry 
2009;66:467-477. 
50. Schultz CC, Koch K, Wagner G, et al. Reduced cortical thickness in first episode schizophrenia. 
Schizophr Res 2009;116:204-209. 
51. Crespo-Facorro B, Roiz-Santiáñez R, Pérez-Iglesias R. Global and regional cortical thinning in 
first-episode psychosis patients: relationships with clinical and cognitive features. Psychol Med 
2011;41:1449-1460. 
52. White T, Magnotta VA, Bockholt HJ, et al. Global white matter abnormalities in schizophrenia: a 
multisite diffusion tensor imaging study. Schizophr Bull 2011;37:222-232. 
53. Inagaki A, Inada T. Dose equivalence of psychotropic drugs. Part xxi. Dose equivalence of novel 
antipsychotics: Blonanserin. Jpn J Clin Psychopharmacol 2008;11:887–890. 
54. Inagaki A, Inada T. Dose equivalence of psychotropic drugs. Part xxii. Dose equivalence of depot 
antipsychotics iii: Risperidone long-acting injection. Jpn J Clin Psychopharmacol 2010;13:1349
–1353. 
55. Lehman AF, Lieberman JA, Dixon LB, et al. Practice guideline for the treatment of patients with 
schizophrenia, second edition. Am J Psychiatry 2004;161:1–56. 
22 
 
Table 1. Demographic data. 
Hc: Healthy controls, Scz: Schizophrenia patients 
( ): standard deviation, a two tailed t-test, b χ2, c haloperidol equivalents were calculated according to 
the practice guidelines for the treatment of schizophrenia patients53-55. 
 Hc Scz P 
Number 35 35  
Age 37.51 (11.68) 36.63  (10.31) 0.74 a 
Gender (M/F) 18/17 23/12 0.23b 
Education (year) 14.48 (2.20) 13.66 (2.23) 0.12 a 
PANSS negative factor - 16.09 (5.85)  
    positive factor  16.23 (5.54)  
     activation factor  7.43 (2.05)  
     depressive factor - 8.31 (2.81)  
     cognitive factor  5.51 (1.62)  
Medication (mg/day, HPD 
equivalent) c 
 10.96 (8.45)  




Table 2. Comparisons of global mean cortical thickness and skeleton mean FA between healthy 
controls (Hc) and schizophrenia patients (Scz) (two tailed t-test). 
GM: gray matter, WM: white matter, ( ): standard deviation, * significant (P < .05)  
 Hc Scz P 
Global mean cortical thickness of GM in hemisphere (mm)  
 left 2.549 (0.105) 2.478 (0.115) 0.008 * 
 right 2.553 (0.099) 2.475 (0.123) 0.005 * 
  
Skeleton mean FA in WM  
 0.419 (0.149) 0.408 (0.196) 0.010 * 
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Table 3. Correlational analysis for skeleton mean FA with global mean cortical thickness in healthy 
controls (Hc) and schizophrenia patients (Scz). 
* significant (P < .05) 





 Pearson’s correlation 
coefficient 
P 
Global mean cortical 
thickness in left 
hemisphere 
0.199  0.25 
 
0.587 <0.001* 
Global mean cortical 
thickness in right 
hemisphere 






Table 4. Partial correlational analysis in the correlation between global mean cortical thickness and 
skeleton mean FA in schizophrenia group. 
* significant (P < .05) 
Correlation with mean 
FA 
[P value] 
No items + Age 
+ Age & 
education 
+Age, education 
& duration of 
illness 
Global mean cortical 










Global mean cortical 














Fig. 1. Statistical maps on FreeSurfer analysis of group comparison of gray matter cortical thickness 
between normal control and schizophrenia subjects (Monte Carlo simulation, P < .05). Maps are 
shown for right and left hemispheres in lateral and medical views, and significant reduction regions 





Fig. 2. Tract-based spatial statistics (TBSS) group comparison of white matter fractional anisotropy 
(FA) between normal control and schizophrenia subjects (threshold-free cluster enhancement 
(TFCE); P < .01). A cluster of significant FA reduction in schizophrenia subjects is shown using the 
tbss_fill implemented in FSL (red-yellow) on the mean FA map and FA skeleton (green color). Axial 







Fig. 3. Scatter plot of the mean FA and global mean cortical thicknesses in healthy controls (Hc: red) 
and schizophrenia patients (Scz: blue) for each hemisphere. 
Left panel: left hemisphere. Hc: r = 0.199, P = .25, Scz: r = 0.587, P < .001. 





Fig. 4. Schematic view of the hypothetical cascade inducing the pathology associated with 
schizophrenia, including the global association between cortical thinning and white matter integrity 
reduction. Note: DISC1, disrupted-in-schizophrenia 1; NMDA, N-methyl-D-aspartate. 
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Supplementary table 1. Comparisons of regional mean cortical thickness in each lobe and cingulate 
cortex between healthy controls (Hc) and schizophrenia patients (Scz) (two tailed t-test). 
( ): standard deviation, * significant (P < .05)  
 Hc Scz P 
Frontal lobe    
  left 2.685 (0.122) 2.603 (0.123) 0.007 * 
  right 2.673 (0.100) 2.596 (0.132) 0.008 * 
Parietal lobe    
  left 2.397 (0.113) 2.333 (0.134) 0.034 * 
  right 2.406 (0.122) 2.336 (0.142) 0.030 * 
Temporal lobe    
 left 2.790 (0.115) 2.727 (0.142) 0.045 * 
 right 2.856 (0.989) 2.782 (0.142) 0.013 * 
Occipital lobe    
 left 1.958 (0.108) 1.914 (0.110) 0.095 
 right 1.972 (0.097) 1.920 (0.107) 0.036 * 
Cingulate cortex    
  left 2.793 (0.155) 2.711 (0.120) 0.016 * 
  right 2.677 (0.147) 2.600 (0.149) 0.034 * 
 
